U.S. markets closed
  • S&P Futures

    4,230.00
    +7.75 (+0.18%)
     
  • Dow Futures

    33,864.00
    +59.00 (+0.17%)
     
  • Nasdaq Futures

    14,202.00
    +36.50 (+0.26%)
     
  • Russell 2000 Futures

    2,289.20
    +4.70 (+0.21%)
     
  • Crude Oil

    70.53
    -0.51 (-0.72%)
     
  • Gold

    1,785.10
    +10.30 (+0.58%)
     
  • Silver

    26.26
    +0.41 (+1.58%)
     
  • EUR/USD

    1.1923
    +0.0013 (+0.11%)
     
  • 10-Yr Bond

    1.5110
    -0.0580 (-3.70%)
     
  • Vix

    17.75
    -0.40 (-2.20%)
     
  • GBP/USD

    1.3938
    +0.0014 (+0.10%)
     
  • USD/JPY

    110.1820
    -0.0490 (-0.04%)
     
  • BTC-USD

    37,679.82
    -1,101.45 (-2.84%)
     
  • CMC Crypto 200

    936.27
    -33.61 (-3.46%)
     
  • FTSE 100

    7,153.43
    -31.52 (-0.44%)
     
  • Nikkei 225

    29,110.37
    +92.04 (+0.32%)
     

OXIS International Inc. (GTBP) Gains As Market Dips: What You Should Know

·2 min read

In the latest trading session, OXIS International Inc. (GTBP) closed at $12.51, marking a +1.54% move from the previous day. This move outpaced the S&P 500's daily loss of 0.25%.

Heading into today, shares of the company had gained 34.94% over the past month, outpacing the Medical sector's gain of 1.44% and the S&P 500's gain of 1.26% in that time.

Wall Street will be looking for positivity from GTBP as it approaches its next earnings report date. In that report, analysts expect GTBP to post earnings of -$0.25 per share. This would mark year-over-year growth of 26.47%.

Investors should also note any recent changes to analyst estimates for GTBP. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 2.62% lower. GTBP is holding a Zacks Rank of #3 (Hold) right now.

The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 203, which puts it in the bottom 21% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
OXIS International Inc. (GTBP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research